-+ 0.00%
-+ 0.00%
-+ 0.00%

CYCLERION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT WITH MEDSTEER AND PROGRESS TOWARD INITIATING PHASE 2 PROOF-OF-CONCEPT STUDY FOR CYC-126 IN TREATMENT-RESISTANT DEPRESSION

Reuters·01/05/2026 21:01:00

Please log in to view news